# Safety Study of Abatacept to Treat Rheumatoid Arthritis (A)

> **NCT01088321** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 81332 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01088321
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2016-11
- **Final completion:** 2016-11
- **Target enrollment:** 81332 (ACTUAL)
- **Last updated:** 2016-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01088321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01088321, "Safety Study of Abatacept to Treat Rheumatoid Arthritis (A)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01088321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*